Mesenchymal Stem Cell Therapy
Mesenchymal Stem Cells or Multipotent Mesenchymal Stromal Cells (collectively referred to as MSCs) are currently being tested in a number of clinical trials for various diseases including graft-versus-host disease, Crohn’s disease, myocardial infarction, stroke, diabetes, cartilage defects, and many...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Totowa, NJ :
Humana Press : Imprint: Humana Press,
2013.
|
| Σειρά: | Stem Cell Biology and Regenerative Medicine
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Scaling-up Ex-vivo Expansion of Mesenchymal Stem/Stromal Cells for Cellular Therapies
- Mesenchymal Stromal Cell Mechanisms of Immunomodulation and Homing
- Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy?
- The Biology of Mesenchymal Stem Cells in Health and Disease and its Relevance to MSC-based Cell Delivery Therapies
- Pulmonary Clinical Applications for Mesenchymal Stem Cells
- Stem Cell Therapy for Bone Disorders
- Mesenchymal Stem Cell Therapies for Bone and Tendon Conditions
- Mesenchymal Stromal Cells (MSC) and the Repair of Cartilage Tissue
- Mesenchymal Stem Cells and Haematopoietic Stem Cell Culture
- Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus-Host Disease and Graft Failure after Hematopoietic Stem Cell Transplantation and Future Challenges
- Mesenchymal Stromal Cell Therapy in Crohn’s Disease
- Application of Mesenychymal Stem Cells in Amyotrophic Lateral Sclerosis
- Mesenchymal Stem Cell Therapy for Heart Disease
- Advances in Lentivector-based Cell Therapy with Mesenchymal Stem Cells
- Genetically Engineered Mesenchymal Stem Cells for Cell and Gene Therapy
- Optimal Tissue Sources of Mesenchymal Stromal Cells for Clinical Trials
- Regulatory Considerations Applicable to Manufacturing of Human Placenta-derived Mesenchymal Stromal Cells (MSC) Used in Clinical Trials in Australia and Comparison to USA and European Regulatory Frameworks
- Mesenchymal Stem Cell Therapy for Peripheral Vascular Diseases
- Mesenchymal Stromal Cells in the Clinic: What do the clinical trials say?.
